Page last updated: 2024-08-23

bromocriptine and Absence Status

bromocriptine has been researched along with Absence Status in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alam, MS; Ansari, MA; Ashraf, GM; Barkat, MA; Barreto, GE; Javed, MN; Khan, A; Maqbool, A; Nigar, S; Pottoo, FH; Rasheed, R; Tabassum, N1
von Werder, K1
Ganesh, V; Iffy, L; McArdle, JJ1
Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H1

Other Studies

4 other study(ies) available for bromocriptine and Absence Status

ArticleYear
The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy.
    Molecular neurobiology, 2019, Volume: 56, Issue:2

    Topics: Animals; Anticonvulsants; Bromocriptine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Female; Fluoxetine; Hippocampus; Male; Mice; Neurons; Oxidative Stress; Pilocarpine; Raloxifene Hydrochloride; Status Epilepticus

2019
[Bromocriptine and puerperal seizures].
    Zentralblatt fur Gynakologie, 1996, Volume: 118, Issue:7

    Topics: Adult; Bromocriptine; Cerebral Hemorrhage; Female; Hormone Antagonists; Humans; Ischemic Attack, Transient; Lactation; Prolactin; Puerperal Disorders; Status Epilepticus

1996
Intracerebral hemorrhage in normotensive mothers using bromocriptine postpartum.
    Zentralblatt fur Gynakologie, 1996, Volume: 118, Issue:7

    Topics: Adult; Bromocriptine; Cerebral Hemorrhage; Female; Follow-Up Studies; Hormone Antagonists; Humans; Hypertension; Lactation; Neurologic Examination; Puerperal Disorders; Status Epilepticus

1996
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
    Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:6

    Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinson Disease; Status Epilepticus

1999